Psychology Today

Am J Psychiatry current issue

Psychology Headlines Around the World

Psych Central News

Clinical Psychology and Psychiatry Arena - New Titles

Schizophrenia News

Showing posts with label Ecstasy for treatment of traumatic anxiety. Show all posts
Showing posts with label Ecstasy for treatment of traumatic anxiety. Show all posts

1/10/2009

Ecstasy for treatment of traumatic anxiety

TREATMENT with a pharmacological version of the drug ecstasy makes PTSD patients more receptive to psychotherapy, and contributes to lasting improvement. Norwegian researchers explain why.People who have survived severe trauma - such as war, torture, disasters, or sexual assault - will often experience after-effects, in a condition called posttraumatic stress disorder (PTSD). The symptoms can include anxiety, uncontrolled emotional reactions, nightmares, intrusive memories, sleep and concentration difficulties, evasion of situations that resemble the trauma, and feelings of shame or amnesia. For many, the condition gradually goes away by itself. Other individuals experience PTSD as a chronic condition that needs treatment, which typically involves drugs that help with anxiety and depression, and/or psychotherapy.More than just happy pillsPsychotherapy usually involves a combination of talk sessions and tasks. In exposure therapy, the focus is to help the patient digest the traumatic event in a safe context. So the patient realizes that the memories of the traumatic event and the situation surrounding it are not dangerous. The patient learns to deal with the traumatic incident as a painful memory, and not as if it will happen again.“Studies show that exposure therapy can be a very effective treatment of post traumatic disorders. Yet far too many patients receive treatment only with drugs. But anxiety reducing drugs and anti-depressants may work against our efforts and reduce the patient’s emotional learning”, says Psl-+rjan Johansen, a psychologist at the Norwegian University of Science and Technology. Along with Teri Krebs, a neurobiologist at the university, he is now exploring what happens when chronic trauma patients are treated with a combination of psychotherapy and pharmacological versions of ecstasy, MDMA (3,4 methylenedioxy-N-methyl-amphetamine). A U.S. study,* recently conducted by psychiatrist Michael Mithoefer, has shown remarkable success with this combination

: Articles recently published in

ScienceDaily: Educational Psychology News

MedicineNet Depression Specialty

Psychology / Psychiatry News From Medical News Today

MedicineNet Attention Deficit Hyperactivity Disorder (ADHD) Specialty